Analysis
ASML shares fell more than 8% Monday to their lowest level since early June after The Information reported that a Shanghai-based company has begun mass-producing immersion deep ultraviolet lithography tools -- the class of chipmaking equipment that Dutch and US export controls have specifically restricted from sale to China.
The report, citing people familiar with the matter, describes a company that has assembled development teams pulled from other Chinese technology firms, including Shanghai Yuliangsheng Technology, to build the tools domestically. Production scale remains modest by ASML's standards -- roughly five DUV machines built this year, with plans for about 20 next year -- a small fraction of ASML's own annual output. But the trajectory, not the current scale, is what spooked investors.
“But the trajectory, not the current scale, is what spooked investors.”
Immersion DUV lithography sits a tier below the extreme ultraviolet (EUV) machines ASML uniquely produces and has never sold to China, but it remains essential for manufacturing many of the chips used in AI infrastructure, automotive electronics and other high-volume applications. Export controls have restricted China's access to advanced DUV tools specifically to slow its ability to manufacture leading-edge chips domestically.
If the report proves accurate, it represents precisely the outcome export-control skeptics have warned about for years: rather than permanently blocking China's access to advanced lithography, restrictions may simply be accelerating the country's push to build the capability itself, at real but manageable cost and time delay. That's a familiar pattern across other restricted technology categories -- restriction creates pressure, pressure eventually produces domestic substitutes, even if imperfect ones initially.
What to watch: whether the unnamed Shanghai company is formally identified and whether its tools pass credible independent quality benchmarks against ASML's equipment, how ASML's own guidance addresses the competitive threat in its next earnings call, and whether the US and Dutch governments respond with further restrictions or accept the domestic-substitution outcome as a fait accompli.
